Newstral
Article
bizjournals.com on 2015-01-12 02:35
Biogen buys UK-based neuropathic pain drug developer for up to $675M
Related news
Warren Buffett Buys Kroger, Biogen In 4th QuarterForbes
New Hampshire hotel developer buys Chelsea landbizjournals.com
A vote of confidence for Biogen as chairman buys $3M sharesbizjournals.com
Forrester buys Wilton-based SiriusDecisions for $245Mwestfaironline.com
No pain, potential big gain for S.F. drug developerbizjournals.com
Austin-based developer buys Cowboys Dancehall at auction; renovations plannedbizjournals.com
Triad-based hotel developer buys another N.C. sitebizjournals.com
Montpelier-based developer buys old St. Albans Energizer plantWCAX
Maryland-based pain management network buys NJ practicesthedailyrecord.com
Sega Networks buys Cambridge video game developer Demiurge Studiosbizjournals.com
NJ residential developer buys Philips Research campus in Briarcliff Manorwestfaironline.com
Houston developer buys land off Texas 114 in SouthlakeStar Telegram
Brooklyn investment firm buys two Frisco apartments from local developerbizjournals.com
NYC-Based Developer Finalizes Acquisition of Westside Residential Development Sitewestsidetoday.com
Dallas-based developer to build 2,800-acre Frisco communitybizjournals.com
US-based Bitcoin miner Gryphon buys 7,200 rigs from Bitmaincointelegraph.com
Researchers urge medical marijuana over opioids to treat neuropathic painThe Globe and Mail
Atlanta-based developer buys $4.6M warehouse near proposed Jacksonville entertainment districtbizjournals.com
Houston-based developer buys former Steakley Chevrolet site on Northwest HighwayDallas News
Phoenix-based developer buys 60 acres for planned industrial project in Goodyearbizjournals.com